{"schema_version":"secwatch.filing_event.v1","accession":"0001398733-26-000007","form_type":"8-K","ticker":"AQST","cik":"0001398733","company_name":"Aquestive Therapeutics, Inc.","filed_at":"2026-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.987388+00:00","generated_at":"2026-05-15T23:29:56.333918+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"low","headline":"Aquestive Therapeutics files February 2026 investor presentation without new financial data","bullets":["Presentation furnished under Regulation FD; intended for meetings with institutional investors.","Only a title slide was provided in the exhibit; no specific financial figures or guidance.","No updates to product pipeline, revenue, or strategic initiatives were disclosed.","Ticker AQST continues to trade on Nasdaq; corporate address unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001398733-26-000007","json":"https://secwatch.observer/filing/0001398733-26-000007.json","markdown":"https://secwatch.observer/filing/0001398733-26-000007.md","text":"https://secwatch.observer/filing/0001398733-26-000007.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1398733/000139873326000007/0001398733-26-000007-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1398733/000139873326000007/aqst-20260226.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:29:56.333918+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}